Volume 22, Number 6—June 2016
Letter
Ecologic Study of Meningococcal B Vaccine and Neisseria gonorrhoeae Infection, Norway
Figure
1Now a GlaxoSmithKline company.
Page created: May 17, 2016
Page updated: May 17, 2016
Page reviewed: May 17, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.